Beam Therapeutics (NasdaqGS:BEAM) was named one of TIME’s 10 Most Influential Health & Life Science Companies of 2026. The recognition highlights Beam’s progress in base editing gene therapies and its ...
View Beam Global BEEM stock quote prices, financial information, real-time forecasts, and company news from CNN.
Is BEAM a good stock to buy? We came across a bullish thesis on Beam Therapeutics Inc. on r/ValueInvesting by ...
Hosted on MSN
Why did BEAM stock jump 10% in pre-market today?
Shares of Beam Therapeutics Inc (BEAM) jumped more than 10% in pre-market trading on Wednesday, after the biotech firm reported promising early-stage data for its gene-editing therapy (BEAM-302) that ...
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem ...
Beam Therapeutics (BEAM) added ~8% in the premarket on Wednesday after announcing plans to begin pivotal development to support a potential accelerated approval of BEAM-302, its gene editing therapy ...
Investor's Business Daily on MSN
Beam Therapeutics reaches 80-plus relative strength rating benchmark
Beam Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 85.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results